Non-Vascular Stents - Current and Future Players


#303737

N/A

GlobalData

$ 3500

In Stock

 

Non-vascular stent technology has evolved over the years such that these devices are routinely used in clinical practice for different indications. Although it is a mature market, both short and long-term complications associated with non-vascular stents continue to persist. This report focuses on four market categories within the non-vascular stent segment, which includes enteral stents (esophageal, gastroduodenal and colonic stents), pancreatic and biliary stents, airways stents and urinary tract stents (ureteral, prostate and urethral stents). This report provides the competitive assessment with product profiles, pipeline products and the list of players also profiled.

 

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

 

Highlights

 

Key Questions Answered

 

  • Who are the primary market players in this market? Who are the smaller players?
  • What are the strengths of these market players? Weaknesses? Opportunities? Threats?
  • What are the key products in this markets and their features? What are the pipeline products that we expect to see here?

 

Scope

 

  • Gain a high level view of the players and products shaping and driving the non-vascular stent market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Pipeline analysis: comprehensive list of products across different stages of development that would impact the non-vascular stent market with emerging trends and designs in development.
  • Analysis of the current and future market competition in the global non-vascular stent market.

 

Reasons to buy

 

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Drive revenues by understanding the key trends, in currently marketed products and technologies likely to impact the global non-vascular stent market.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

 

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

 

2 Introduction
2.1 Catalyst
2.2 Related Reports
 

3 Competitive Assessment
3.1 Gastrointestinal Stents
3.1.1 Overview
3.1.2 WallFlex (Boston Scientific Corporation)
3.1.3 Evolution (Cook Medical)
3.1.4 Niti-S (Taewoong Medical)
3.1.5 Other Key Marketed Gastrointestinal Stents
3.2 Biliary Stents
3.2.1 Overview
3.2.2 WallFlex Biliary RX (Boston Scientific Corporation)
3.2.3 Cotton-Leung (Amsterdam) (Cook Medical)
3.2.4 Bonastent (EndoChoice)
3.2.5 Other Key Marketed Biliary Stents
3.3 Airway Stents
3.3.1 Overview
3.3.2 Dumon (Novatech)
3.3.3 Aero/Aero DV (Merit Endotek)
3.3.4 Ultraflex (Boston Scientific Corporation)
3.3.5 Other Key Marketed Airway Stents
3.4 Urinary Tract Stents
3.4.1 Overview
3.4.2 Polaris Ultra (Boston Scientific Corporation)
3.4.3 InLay Optima (C.R. Bard)
3.4.4 Other Key Marketed Urinary Tract Stents
 

4 Current and Future Players
4.1 Trends in Corporate Strategy
4.2 Company Profiles
4.2.1 Allium Medical
4.2.2 Boston Scientific Corporation
4.2.3 ConMed
4.2.4 Cook Medical
4.2.5 C.R. Bard
4.2.6 Ella-CS
4.2.7 Merit Endotek
4.2.8 M.I. Tech
4.2.9 Micro-Tech (Nanjing)
4.2.10 Medtronic (Covidien)
4.2.11 Novatech
4.2.12 Olympus
4.2.13 Taewoong Medical
4.2.14 Xlumena
4.2.15 Other Companies
4.2.16 Urinary Tract Stents
 

5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Research Methodology
5.3.1 Overview
5.3.2 Coverage
5.3.3 Secondary Research
5.4 Physicians and Specialists Included in this Study
5.5 Primary Research
5.5.1 Primary Research Key Opinion Leader Interviews
5.5.2 Primary Research Physician and Industry Interviews
5.5.3 Expert Panel Validation
5.6 Forecasting Methodology
5.7 About the Authors
5.7.1 Analysts
5.7.2 Global Head of Healthcare
5.8 About MediPoint
5.9 About GlobalData
5.10 Disclaimer

 

Table 1 WallFlex Family Stent Product Portfolio
Table 2: WallFlex Stent Family SWOT Analysis
Table 3: Evolution Family Stent Product Portfolio
Table 4: Evolution Stent Family SWOT Analysis
Table 5: Niti-S Family Stent Product Portfolio
Table 6: Niti-S Stent Family SWOT Analysis
Table 7: Gastrointestinal Stents, Other Key Marketed Products
Table 8: WallFlex Biliary RX Stent Product Portfolio
Table 9: WallFlex Biliary RX Stent SWOT Analysis
Table 10: Cotton-Leung Stent Product Portfolio
Table 11: Cotton-Leung Stent SWOT Analysis
Table 12: Bonastent Product Portfolio
Table 13: Bonastent Stent SWOT Analysis
Table 14: Biliary Stents, Other Key Marketed Products
Table 15: Dumon Stent Product Portfolio
Table 16: Dumon Stent SWOT Analysis
Table 17: Aero/Aero DV Stent Product Portfolio
Table 18: Aero/Aero DV Stents SWOT Analysis
Table 19: Ultraflex Stent Product Portfolio
Table 20: Ultraflex Stent SWOT Analysis
Table 21: Airway Stents, Other Key Marketed Products
Table 22: Polaris Ultra Stent Product Portfolio
Table 23: Polaris Ultra Stent SWOT Analysis
Table 24: InLay Optima Stent Product Portfolio
Table 25: InLay Optima SWOT Analysis
Table 26: Urinary Tract Stents, Other Key Marketed Products
Table 27: Major Clinical Trials for Enteral Stents
Table 28: Major Clinical Trials for Pancreatic and Biliary Stents
Table 29: Major Clinical Trial for Airway Stents
Table 30: Company Profile Allium Medical
Table 31: Allium Medicals Marketed Non-Vascular Stent Products
Table 32: SWOT Analysis Allium Medical
Table 33: Company Profile Boston Scientific Corporation
Table 34: Boston Scientific Corporations Marketed Non-Vascular Stent Products
Table 35: SWOT Analysis Boston Scientific Corporation
Table 36: Company Profile ConMed
Table 37: ConMed, Key Marketed Non-Vascular Stent Products
Table 38: SWOT Analysis ConMed
Table 39: Company Profile Cook Medical
Table 40: Cook Medical, Key Marketed Non-Vascular Stent Products
Table 41: SWOT Analysis Cook Medical
Table 42: Company Profile C.R. Bard
Table 43: C.R. Bard, Key Marketed Non-Vascular Stent Products
Table 44: SWOT Analysis C.R. Bard
Table 45: Company Profile Ella-CS
Table 46: Ella-CS, Key Marketed Non-Vascular Stent Products
Table 47: SWOT Analysis Ella-CS
Table 48: Company Profile Merit Endotek
Table 49: Merit Endoteks Key Marketed Non-Vascular Stent Products
Table 50: SWOT Analysis Merit Endotek
Table 51: SWOT Analysis M.I. Tech
Table 52: Company Profile Micro-Tech (Nanjing)
Table 53: Micro-Tech (Nanjing), Key Marketed Non- Vascular Stent Products
Table 54: SWOT Analysis Micro-Tech (Nanjing)
Table 55: Medtronic (Covidien) Marketed Non-Vascular Stent Products
Table 56: SWOT Analysis Medtronic (Covidien)
Table 57: Company Profile Novatech
Table 58: Novatechs Marketed Non-Vascular Stent Products
Table 59: SWOT Analysis Novatech
Table 60: Company Profile Olympus
Table 61: Olympus Key Marketed Non-Vascular Stent Products
Table 62: SWOT Analysis Olympus
Table 63: Company Profile Taewoong Medical
Table 64: Taewoong Medical Marketed Products
Table 65: SWOT Analysis Taewoong Medical
Table 66: Company Profile Xlumena
Table 67: Xlumenas Key Marketed Non-Vascular Stent Products
Table 68: SWOT Analysis Xlumena
Table 69: Other Companies Involved in the Non-Vascular Stents Market, 2014
Table 70: Non-Vascular Stents - Primary Call Count by Country
Table 71: Non-Vascular Stents - Primary Call Count by Type

 

Figure 1: Non-Vascular Stents - Primary Call Count by Country
Figure 2: Non-Vascular Stents - Primary Call Count by Type